Farag, Mena;
Bahra, Anish;
(2023)
Secondary cough headache: Independent course of headache and response to a COX-2 inhibitor.
Clinical Neurology and Neurosurgery
, 227
, Article 107646. 10.1016/j.clineuro.2023.107646.
Preview |
Text
Farag_Manuscript.pdf Download (462kB) | Preview |
Abstract
We report on two patients with secondary cough headache who responded to the cyclo-oxygenase-2 (COX-2) inhibitor etoricoxib and showed an independent temporal course. This case report shows that secondary cough headache can also respond to medical treatment and can respond to a COX-2 inhibitor, not previously reported. As is seen in primary cough headache, the headache disorder can go into natural remission (case 1) while the secondary pathology progresses and conversely, persist once the secondary pathology has resolved (case 2). The course of the headache and that of the secondary pathology do not necessarily correlate. It is, therefore, proposed that any treatment of the secondary pathology is independent to that of the headache. In NSAID-intolerant cases a COX-2 inhibitor can be trialled first line.
Archive Staff Only
 |
View Item |
